Melanotan-2 binds to melanocortin-1 receptors (MC1R) on melanocytes in the basal epidermis, triggering a cAMP-mediated signaling cascade that activates microphthalmia-associated transcription factor (MITF)
For patients who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone, GLP-1 therapy offers a potent alternative with greater potency and longer half-life compared to some other GLP-1 RA therapies
P., Rosen, S
The researchers notably found that epithalamin not only produces direct antioxidant effects, but also stimulates the expression of antioxidant enzymes like superoxide dismutase and ceruloplasmin [10]
These early changes reflect fat redistribution rather than massive fat loss
In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future